The effect of leech therapy on carpal tunnel syndrome

Not Applicable

Recruiting

Conditions: The effect of leech therapy on Nerve condition in carpal tunnel syndrome patients.
Other lesions of median nerve

Registration Number: IRCT20180909040977N1

Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

The presence of clinical symptoms and having positive Tinel, Fallen and carpal compersion tests
Having positive paraclinical findings (nerve conduction velocity and electromyography) detected by electrodiagnosis and the grades must be in intermediate level by neurologist and neurologist specialist diagnosis.
Satisfaction should be gained by the use of one of two methods.
Age between 30-60 years

Exclusion Criteria

The presence of rheumatic disease, rheumatoid arthritis and other upper limb disorders, coagulation problems, diabetes, hypothyroidism, gout, lupus erythematosus, acromegaly, chronic kidney failure, and diseases that impede CTS symptoms.
Pregnancy for up to a year and mental retardation and anemia
Frequent fracture or trauma to the wrist and wrist surgery
Injection of intra-articular corticosteroid in the wrists during the past 3 months
Immune system disorders, severe allergic allergy, use of neuropathic drugs, use of non-steroidal anti-inflammatory drugs during the last two weeks
History of stroke syndrome

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abnormalities in electromyography and nerve study. Timepoint: Once on the first day of the study and once on day 60. Method of measurement: Electromyographic machine Nihon kohden model.;Pain score on the analog scale visual pain. Timepoint: In 4 steps, at the beginning of the study (before treatment or leech therapy), on day 15, day 30 and day. Method of measurement: Visual Analogue Scale.;Severity of symptoms and functional status. Timepoint: In 4 stages, at the time of entering the study (before treatment or leech therapy), on day 15, day 30 and day 60. Method of measurement: Boston Clinical Symptom Intensity Questionnaire.

Secondary Outcome Measures